August 17, 2009 — An experimental GE Healthcare imaging agent called DaTSCAN that can detect loss of dopaminergic neurons — seen in diseases such as Parkinson's disease (PD) and dementia with Lewy ...
(RTTNews) - GE Healthcare (GE) announced on Thursday that DaTscan was approved by FDA for use in patients with suspected Dementia with Lewy Bodies or DLB. DaTscan is a radiopharmaceutical imaging ...